Q4 2020 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -1.240 | ||||||
REV | 827.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
Ticker | Company | Price | Change | Chg % | Mkt Cap | |
---|---|---|---|---|---|---|
KDNY | Chinook Therapeutics | 15.34 | -0.56 | -3.52% | 650.1M |
You can purchase shares of Chinook Therapeutics (NASDAQ: KDNY) through any online brokerage.
Other companies in Chinook Therapeutics’s space includes: Orchard Therapeutics (NASDAQ:ORTX), Eagle Pharmaceuticals (NASDAQ:EGRX) and Immatics (NASDAQ:IMTX).
The latest price target for Chinook Therapeutics (NASDAQ: KDNY) was reported by Wedbush on 2021-01-06. The analyst firm set a price target for 28.00 expecting KDNY to rise to within 12 months (a possible 82.53% upside). 5 analyst firms have reported ratings in the last year.
The stock price for Chinook Therapeutics (NASDAQ: KDNY) is $15.34 last updated Mon Apr 19 2021 20:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Chinook Therapeutics.
There is no upcoming split for Chinook Therapeutics.